A Hybrid Emotion-focused Treatment for Chronic Pain Patients With Emotional Problems

December 29, 2018 updated by: Örebro University, Sweden

An Randomized Controlled Trial (RCT) Testing the Effectiveness of a Hybrid Emotion-focused Treatment for Chronic Pain Patients With Co-occurring Emotional Problems

The aim of this project is to evaluate a hybrid emotion-focused treatment protocol, specifically developed for individuals who suffer from co-occurring chronic pain and clinical levels of anxiety and/or depressive symptoms.

Specific questions relating to treatment outcome:

  1. Does a hybrid emotion-focused treatment lead to a decrease in comorbid emotional symptoms (pain-related fear, anxiety, depression)?
  2. Does a hybrid emotion-focused treatment lead to an increase in functional ability, improvement in work status and decrease in medication use?
  3. Does a hybrid emotion-focused treatment lead to better treatment effect on the above outcome variables compared to an active comparison group?

    Specific questions relating to the process of change:

  4. Are therapeutic effects of the hybrid emotion-focused treatment mediated by changes in proposed transdiagnostic emotion regulation process variables (worry, rumination, cognitive and behavioral avoidance, emotional suppression)?

Study Overview

Detailed Description

Design. A randomized controlled trial in which chronic pain patients with co-occurring emotional problems will receive either:

  1. A hybrid individual treatment combining emotion regulation focused Dialectical Behavior Therapy (DBT) with standard exposure methodology. The treatment targets the transdiagnostic psychological processes that have been shown to maintain emotional dysregulation.
  2. An active control condition receiving internet-delivered pain management treatment based on Cognitive Behavioral principles. This treatment is evidence-based and thus provides a credible and ethical active comparison group.

Selection. N=84 (ES=.5, p=.05 and ß=.80; based on an estimated between group difference on the Hospital Anxiety and Depression Scale, and compensating for an approximate drop out rate of 20% per condition). Patients will be recruited through pain rehabilitation units in Orebro and Linkoping and via advertisements in the local newspapers.

Procedure. Patients will be examined and screened by trained professionals to exclude individuals with red flags (serious medical illnesses that explain pain conditions), a risk of suicide, and/or need of emergency psychiatric care. After screening and baseline assessment, participants will be randomized to receive either the individual face-to-face hybrid emotion focused treatment (10-15 weekly or biweekly sessions) or the individual, guided, internet-based Cognitive Behavior Therapy (iCBT) treatment for pain (10 weekly sessions). The internet treatment is therapist guided through email contact. The hybrid treatment will be conducted by a trained and supervised licensed clinical psychologist and the internet guidance will be provided by trained and supervised clinical psychologists in their final stage of clinical training. The hybrid emotion-focused treatment integrates procedures from exposure and DBT with a clear uniting conceptualization focused on targeting underlying processes that maintain co-occurring chronic pain and emotional problems.

Study Type

Interventional

Enrollment (Actual)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linköping, Sweden, 58185
        • Smärt- och rehabiliteringscentrum Linköping
      • Örebro, Sweden, 70182
        • Center for Health and Medical Psychology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Chronic musculoskeletal pain (> 6 months duration), not emanating from malignancies, systemic diseases (e.g. rheumatoid arthritis) or localized single-joint osteoarthritic conditions in the lower extremities (e.g. knee-osteoarthritis, hip- osteoarthritis).
  • Functional problems due to pain (defined as > 10 points on question 21-24 of the Orebro Musculoskeletal Pain Questionnaire).
  • Emotional problems (defined as >7 points (cut-off for a probable case) on at least one of the two subscales (anxiety and depression) of the Hospital Anxiety and Depression Scale).

Exclusion Criteria:

  • Severe psychiatric disorders that may require immediate other treatment (alcohol abuse, bipolar disorder, psychotic disorders),
  • Currently in psychological treatment elsewhere,
  • Recently been started on psychopharmacological treatment for depression and/or anxiety (cut off criterion: < 3 months prior to planned treatment start),
  • Insufficient mastery of the Swedish language written as well as spoken,
  • No personal computer available.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hybrid

The hybrid emotion-focused treatment consists of 10-15 individual 1/1,5 hour sessions. It includes the following stages (examples of methods in parathesis)

Stage I. Analysis of emotions and pain (Validation, Compassion, Chain analysis, Values & goals).

Stage II. Developing skills (Dialectics, Self-validation, Self-compassion, emotion regulation skills).

Stage III. Exposure training (Exposure for emotionally sensitive stimuli, exposure in vivo for avoided movements).

Stage IV. Maintenance (Identifying key elements, Planning for flare-ups).

The hybrid emotion-focused treatment integrates procedures from exposure and dialectical behavior therapy (DBT) with a clear uniting conceptualization focused on targeting underlying processes that maintain co-occurring chronic pain and emotional problems.
Active Comparator: internet Cognitive Behavior Therapy (iCBT)
CBT pain treatment, delivered via the internet consists of 8, weekly, modules and includes topics such as pain education, pain coping strategies (e.g. pacing), relaxation, cognitive restructuring, problem solving, stress and sleep management, conflict resolution. Patients read materials included in each module and do homework tasks on which they report back to the therapist via the internet. The therapist gives written feedback and guidance after each module. See reference for details.
A state-of-the-art CBT pain treatment, delivered via the internet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Montgomery Asberg depression rating scale (MADRS) change
Time Frame: baseline, 3 months, 12 months
change in self rated depression (from pretreatment, to post treatment and follow up) Scale range 0-60 (higher values worse outcome)
baseline, 3 months, 12 months
Multidimensional Pain Inventory (MPI) change
Time Frame: baseline, 3 months, 12 months
change in pain intensity and interference (from pretreatment, to post treatment and follow up). Subscale pain intensity range 0-12, subscale pain interference range 0-66 (for both subscales higher values worse outcome)
baseline, 3 months, 12 months
Pain Catastrophizing Scale (PCS) change
Time Frame: baseline, 3 months, 12 months
change in pain catastrophizing (from pretreatment, to post treatment and follow up). Scale range 0-52 (higher values worse outcome).
baseline, 3 months, 12 months
Generalised Anxiety Disorder 7-item Scale (GAD-7) change
Time Frame: baseline, 3 months, 12 months
change in general anxiety (from pretreatment, to post treatment and follow up). Scale range 0-27 (higher values worse outcome).
baseline, 3 months, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficulties in Emotion Regulation Scale (DERS) change
Time Frame: baseline, 1.5 months, 3 months
change in emotion regulation (from pretreatment, to mid- and post treatment)
baseline, 1.5 months, 3 months
The Behavior Activation for Depression Scale (BADS) change
Time Frame: baseline, 1.5 months, 3 months
change in behavioral activation (from pretreatment, to mid- and post treatment)
baseline, 1.5 months, 3 months
Self-Compassion scale-12 (SCS) change
Time Frame: baseline, 3 months
change in self compassion (from pretreatment to post treatment)
baseline, 3 months
Insomnia Severity Index (ISI) change
Time Frame: baseline, 3 months
change in insomnia (from pretreatment to post treatment)
baseline, 3 months
Tampa Scale for Kinesiophobia (TSK) change
Time Frame: baseline, 3 months
change in fear avoidance (from pretreatment to post treatment)
baseline, 3 months
Chronic Pain Acceptance Questionnaire (CPAQ) change
Time Frame: baseline, 3 months
change in pain acceptance (from pretreatment to post treatment)
baseline, 3 months
Lisat 11 change
Time Frame: baseline, 3 months, 12 months
change in quality of life (from pretreatment to post treatment and follow up)
baseline, 3 months, 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
adverse effects
Time Frame: 3 months
adverse treatment effects, measured post treatment
3 months
treatment satisfaction questionnaire
Time Frame: 3 months
self report satisfaction with treatment measured at post treatment
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Katja Boersma, PhD, Örebro University, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

September 1, 2018

Study Registration Dates

First Submitted

June 1, 2016

First Submitted That Met QC Criteria

June 20, 2016

First Posted (Estimate)

June 21, 2016

Study Record Updates

Last Update Posted (Actual)

January 2, 2019

Last Update Submitted That Met QC Criteria

December 29, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HYBRID

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Hybrid

3
Subscribe